Novavax (NVAX) Misses Q3 EPS, Revenue Beats; Guides to Low End
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 10.35 +0.67 (6.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.68 | 52 Week High | $9.23 | |||
| Open | $10.01 | 52 Week Low | $1.16 | |||
| Day High | $10.47 | P/E | N/A | |||
| Day Low | $9.84 | EPS | $-0.30 | |||
| Volume | 4,031,582 | |||||
